Edible plant extracts and foodborne phytochemicals demonstrate cardioprotective efficacy against doxorubicin-induced oxidative stress and cardiotoxicity in various in vivo and in vitro models.
Do edible plant extracts and foodborne phytochemicals reduce doxorubicin-induced cardiotoxicity in in vivo and in vitro models?
Edible plant extracts and foodborne phytochemicals may offer cardioprotective benefits against doxorubicin-induced cardiotoxicity by mitigating oxidative stress.
Cardiotoxicity is a frequent undesirable phenomenon observed during oncological treatment that limits the therapeutic dose of antitumor drugs and thus may decrease the effectiveness of cancer eradication. Almost all antitumor drugs exhibit toxic properties towards cardiac muscle. One of the underlying causes of cardiotoxicity is the stimulation of oxidative stress by chemotherapy. This suggests that an appropriately designed diet or dietary supplements based on edible plants rich in antioxidants could decrease the toxicity of antitumor drugs and diminish the risk of cardiac failure. This comprehensive review compares the cardioprotective efficacy of edible plant extracts and foodborne phytochemicals whose beneficial activity was demonstrated in various models in vivo and in vitro. The studies selected for this review concentrated on a therapy frequently applied in cancer, anthracycline antibiotic-doxorubicin-as the oxidative stress- and cardiotoxicity-inducing agent.
Koss‐Mikołajczyk et al. (Fri,) conducted a review in Cardiotoxicity during cancer chemotherapy (doxorubicin). Edible plant extracts and foodborne phytochemicals was evaluated on Cardioprotective efficacy against doxorubicin-induced cardiotoxicity. Edible plant extracts and foodborne phytochemicals demonstrate cardioprotective efficacy against doxorubicin-induced oxidative stress and cardiotoxicity in various in vivo and in vitro models.